Showing 541-560 of 644 for: Cochrane Systematic Reviews > Psychiatric and substance abuse 
- Second‐generation antidepressants for treatment of seasonal affective disorder
Cochrane Systematic Reviews, 4-Mar-2021
Seasonal affective disorder (SAD) is a seasonal pattern of recurrent depressive episodes that is often treated with second-generation antidepressants (SGAs), light therapy, or psychotherapy.
- Second-generation antipsychotics for anxiety disorders
Cochrane Systematic Reviews, 26-Oct-2011
Anxiety disorders are common and disabling conditions, with a lifetime prevalence of 17% in the general population. Due to high rates of treatment resistance, there is interest in new pharmacological treatment options such as second-generation antipsychot
- Second-generation antipsychotics for major depressive disorder and dysthymia
Cochrane Systematic Reviews, 18-Jan-2012
Major depressive disorder (MDD) is a common condition with a lifetime prevalence of 15% to 18%, which leads to considerable suffering and disability. Some antipsychotics have been reported to induce remission in major depression, when added to an antidepr
- Second-generation antipsychotics for obsessive compulsive disorder
Cochrane Systematic Reviews, 10-Nov-2010
Obsessive compulsive disorder (OCD) is a psychiatric disorder which has been shown to affect 2 to 3.5% of people during their lifetimes. Inadequate response occurs in 40% to 60% of people that are prescribed first line pharmaceutical treatments (selective
- Sedatives for opioid withdrawal in newborn infants
Cochrane Systematic Reviews, 18-May-2021
Neonatal abstinence syndrome (NAS) due to opioid withdrawal may result in disruption of the mother–infant relationship, sleep–wake abnormalities, feeding difficulties, weight loss, seizures and neurodevelopmental problems.
- Selective serotonin reuptake inhibitors (SSRIs) and serotonin‐norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults
Cochrane Systematic Reviews, 1-Apr-2015
This is an updated version of the original Cochrane review published in 2005 on selective serotonin reuptake inhibitors (SSRIs) for preventing migraine and tension-type headache. The original review has been split in two parts and this review now only reg
- Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
Cochrane Systematic Reviews, 8-Aug-2013
Autism spectrum disorders (ASD) are characterised by abnormalities in social interaction and communication skills, as well as stereotypic behaviours and restricted activities and interests. Selective serotonin reuptake inhibitors (SSRIs) are prescribed fo
- Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression
Cochrane Systematic Reviews, 31-Oct-2008
The relatively new class of antidepressant, the selective serotonin reputake inhibitors (SSRIs), may be better tolerated than the older tricyclic antidepressants. This review compares the efficacy of SSRIs with other antidepressants.
- Selective serotonin re‐uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)
Cochrane Systematic Reviews, 23-Jan-2008
Obsessive compulsive disorder is a common and disabling disorder. A significant proportion of patients manifest a chronic course. Individual randomised controlled trials (RCTs) have shown that selective serotonin re-uptake inhibitors (SSRIs) are effective
- Selective serotonin reuptake inhibitors for premenstrual syndrome
Cochrane Systematic Reviews, 7-Jun-2013
Premenstrual syndrome (PMS) is a common cause of physical, psychological and social problems in women of reproductive age. The key characteristic of PMS is the timing of symptoms, which occur only during the two weeks leading up to menstruation (the lutea
- Selegiline for Alzheimer's disease
Cochrane Systematic Reviews, 12-May-2008
Alzheimer's disease is the most common cause of dementia in older people accounting for some 60% of cases with late-onset cognitive deterioration. It is now thought that several neurotransmitter dysfunctions are involved from an early stage in the pathoge
- Self-help and guided self-help for eating disorders
Cochrane Systematic Reviews, 5-Nov-2008
Anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED) and eating disorder not otherwise specified (EDNOS) are common and disabling disorders. Many patients experience difficulties accessing specialist psychological treatments. Pure self
- Sensory environment on health-related outcomes of hospital patients
Cochrane Systematic Reviews, 15-Feb-2012
Hospital environments have recently received renewed interest, with considerable investments into building and renovating healthcare estates. Understanding the effectiveness of environmental interventions is important for resource utilisation and providin
- Sertindole for schizophrenia
Cochrane Systematic Reviews, 20-Jul-2005
Sertindole is an atypical antipsychotic, which is thought to give a lower incidence of extrapyramidal side effects at clinically effective doses than typical antipsychotic drugs. In December 1998, Lundbeck Ltd., the manufacturers of sertindole, voluntaril
- Sertindole versus other atypical antipsychotics for schizophrenia
Cochrane Systematic Reviews, 15-Apr-2009
In many countries of the industrialised world second generation (atypical) antipsychotics have become the first line drug treatment for people with schizophrenia. The question as to whether and, if so, how much the effects of the various second generation
- Sertraline versus other antidepressive agents for depression
Cochrane Systematic Reviews, 14-Apr-2010
The National Institute for Health and Clinical Excellence clinical practice guideline on the treatment of depressive disorder recommended that selective serotonin reuptake inhibitors should be the first-line option when drug therapy is indicated for a dep
- Shared decision making interventions for people with mental health conditions
Cochrane Systematic Reviews, 20-Jan-2010
One person in every four will suffer from a diagnosable mental health condition during their life course. Such conditions can have a devastating impact on the lives of the individual, their family and society. Increasingly partnership models of mental hea
- Short‐term psychodynamic psychotherapies for common mental disorders
Cochrane Systematic Reviews, 1-Jul-2014
Since the mid-1970s, short-term psychodynamic psychotherapies (STPP) for a broad range of psychological and somatic disorders have been developed and studied. Early published meta-analyses of STPP, using different methods and samples, have yielded conflic
- Silver acetate for smoking cessation
Cochrane Systematic Reviews, 12-Sep-2012
Silver acetate produces an unpleasant taste when combined with cigarettes, thereby producing an aversive stimulus. It has been marketed in various forms with the aim of extinguishing the urge to smoke, by pairing the urge with an unpleasant stimulus.
- Simple behavioural interventions for nocturnal enuresis in children
Cochrane Systematic Reviews, 17-Jul-2013
Nocturnal enuresis (bedwetting) is a socially disruptive and stressful condition which affects around 15% to 20% of five year olds and up to 2% of adults. Although there is a high rate of spontaneous remission, the social, emotional and psychological cost
